|
US5643566A
|
|
Formulation processes for lipophilic proteins
|
|
US5702699A
|
|
Process for the recovery of lipophilic proteins
|
|
SG132994G
|
|
Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids and kits therefor
|
|
US5372943A
|
|
Lipid microemulsions for culture media
|
|
US5250186A
|
|
HPLC light scattering detector for biopolymers
|
|
US5156964A
|
|
Methods for adapting cells for increased product production through exposure to ammonia
|
|
WO9206196A1
|
|
Gro genes, proteins, and uses thereof
|
|
WO9203473A1
|
|
Cd18 peptide medicaments for the treatment of disease
|
|
CA2090121A1
|
|
Uses of colony stimulating factor-1
|
|
WO9203151A1
|
|
Uses of recombinant colony stimulating factor-1
|
|
AU8337291A
|
|
Methods for the identification of cytokine convertase inhibitors
|
|
US5166133A
|
|
Method for inhibing adhesion of white blood cells to endothelial cells
|
|
AU8081491A
|
|
Compositions and methods for identifying biologically active molecules
|
|
WO9117258A1
|
|
Inhibitors of factor xii activation and applications thereof
|
|
US5268274A
|
|
Methods and nucleic acid sequences for the expression of the cellulose synthase operon
|
|
WO9117249A1
|
|
Interleukin-1 antagonist and uses thereof
|
|
AU7554691A
|
|
Purified rap gaps, rap gap sequences, and uses thereof
|
|
WO9112334A1
|
|
Inhibitor of cytokine activity and applications thereof
|
|
WO9108774A1
|
|
Cytokine antibody for the treatment of sepsis
|
|
US5173482A
|
|
Immunosuppressive analogues and derivatives of succinylacetone
|
